142 related articles for article (PubMed ID: 31432410)
21. Proteomics-based technologies in the discovery of biomarkers for multiple sclerosis in the cerebrospinal fluid.
Lourenço AS; Baldeiras I; Grãos M; Duarte CB
Curr Mol Med; 2011 Jun; 11(4):326-49. PubMed ID: 21506919
[TBL] [Abstract][Full Text] [Related]
22. The use of a quantitative cysteinyl-peptide enrichment technology for high-throughput quantitative proteomics.
Liu T; Qian WJ; Camp DG; Smith RD
Methods Mol Biol; 2007; 359():107-24. PubMed ID: 17484113
[TBL] [Abstract][Full Text] [Related]
23. Application of 2D-DIGE and iTRAQ Workflows to Analyze CSF in Gliomas.
Rao AA; Mehta K; Gahoi N; Srivastava S
Methods Mol Biol; 2019; 2044():81-110. PubMed ID: 31432408
[TBL] [Abstract][Full Text] [Related]
24. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
25. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
26. Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery.
Núñez Galindo A; Kussmann M; Dayon L
Anal Chem; 2015 Nov; 87(21):10755-61. PubMed ID: 26452177
[TBL] [Abstract][Full Text] [Related]
27. Proteome profiling of human cerebrospinal fluid: exploring the potential of capillary electrophoresis with surface modified capillaries for analysis of complex biological samples.
Zuberovic A; Hanrieder J; Hellman U; Bergquist J; Wetterhall M
Eur J Mass Spectrom (Chichester); 2008; 14(4):249-60. PubMed ID: 18756023
[TBL] [Abstract][Full Text] [Related]
28. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
29. A systematic N-terminal peptide quantitative labeling strategy for differential proteomic analysis.
Liu X; Zhang J; Zheng Z; Yang X; Jia W; Li L; Gong Y; Cai Y; Zhu Y; He F; Ying W; Qian X
Proteomics Clin Appl; 2010 Jul; 4(6-7):633-43. PubMed ID: 21137082
[TBL] [Abstract][Full Text] [Related]
30. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
[TBL] [Abstract][Full Text] [Related]
31. Large-Scale and Deep Quantitative Proteome Profiling Using Isobaric Labeling Coupled with Two-Dimensional LC-MS/MS.
Gritsenko MA; Xu Z; Liu T; Smith RD
Methods Mol Biol; 2016; 1410():237-47. PubMed ID: 26867748
[TBL] [Abstract][Full Text] [Related]
32. Redox Proteomics in Human Biofluids: Sample Preparation, Separation and Immunochemical Tagging for Analysis of Protein Oxidation.
Di Domenico F; Perluigi M; Butterfield DA
Methods Mol Biol; 2016; 1303():391-403. PubMed ID: 26235080
[TBL] [Abstract][Full Text] [Related]
33. Robust two-dimensional separation of intact proteins for bottom-up tandem mass spectrometry of the human CSF proteome.
Bora A; Anderson C; Bachani M; Nath A; Cotter RJ
J Proteome Res; 2012 Jun; 11(6):3143-9. PubMed ID: 22537003
[TBL] [Abstract][Full Text] [Related]
34. Identification of Missing Proteins in Normal Human Cerebrospinal Fluid.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4315-4319. PubMed ID: 30106588
[TBL] [Abstract][Full Text] [Related]
35. Advancing cerebrospinal fluid biomarker discovery by mass spectrometry.
Gobom J
Neurodegener Dis Manag; 2015 Oct; 5(5):371-3. PubMed ID: 26477620
[No Abstract] [Full Text] [Related]
36. Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates.
Hanrieder J; Wetterhall M; Enblad P; Hillered L; Bergquist J
J Neurosci Methods; 2009 Mar; 177(2):469-78. PubMed ID: 19263575
[TBL] [Abstract][Full Text] [Related]
37. Application of an Aptamer-Based Proteomics Assay (SOMAscan™) in Rat Cerebrospinal Fluid.
Simats A; Ramiro L; Montaner J; García-Berrocoso T
Methods Mol Biol; 2019; 2044():221-231. PubMed ID: 31432415
[TBL] [Abstract][Full Text] [Related]
38. Proteomics analysis of human cerebrospinal fluid.
Yuan X; Desiderio DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
[TBL] [Abstract][Full Text] [Related]
39. In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.
Mouton-Barbosa E; Roux-Dalvai F; Bouyssié D; Berger F; Schmidt E; Righetti PG; Guerrier L; Boschetti E; Burlet-Schiltz O; Monsarrat B; Gonzalez de Peredo A
Mol Cell Proteomics; 2010 May; 9(5):1006-21. PubMed ID: 20093276
[TBL] [Abstract][Full Text] [Related]
40. Post-digestion ¹⁸O exchange/labeling for quantitative shotgun proteomics of membrane proteins.
Ye X; Luke BT; Johann DJ; Chan KC; Prieto DA; Ono A; Veenstra TD; Blonder J
Methods Mol Biol; 2012; 893():223-40. PubMed ID: 22665304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
